Announcements Trials
Browse Landscape

Phase

Phase 2 98Phase 1 37Phase 3 21Phase 1/2 21Phase NA 18Phase 2/3 5Phase 4 4Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 22Lymphoid 13Myeloid 5Plasma cell 2Other neoplasm 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Venous Thromboembolism 2Thrombosis 2Thrombocytopenia 2Primary Myelofibrosis 2Lymphoma 2Anemia, Aplastic 2Venous Thrombosis 1Thromboembolism 1Thrombocytosis 1Pulmonary Embolism 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Hodgkin Disease 1Hematologic Neoplasms 1Genetic Diseases, Inborn 1Cytopenia 1Burkitt Lymphoma 1Anemia, Refractory, with Excess of Blasts 1Anemia, Hemolytic, Autoimmune 1Anemia 1

Interventions

Transplantation 1Cord Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Leukemia × Classical hematology × Clear all
NCT00212407 2018-11-02

New York Blood Center National Cord Blood Program

New York Blood Center

Phase EARLY_PHASE1 Terminated
4,476 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Aplastic, Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoma, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡